Percutaneous coronary intervention in elderly patients: is it beneficial?
- 1 January 2011
- journal article
- review article
- Vol. 38 (4) , 398-403
Abstract
Persons aged 65 years or older, often referred to as the elderly, are a rapidly increasing population in the United States. Cardiovascular disease is the most common cause of morbidity and death in this age group, and acute coronary syndrome accounts for a significant proportion of the deaths. Percutaneous coronary intervention is a well-established treatment for acute coronary syndrome and symptomatic coronary artery disease. However, community studies have shown that elderly patients are less likely to undergo revascularization, perhaps due to a "treatment-risk" paradox: elderly patients-at higher risk of morbidity and death from acute coronary syndrome-are denied revascularization even though they are likely to benefit from it. Age alone is one of the many reasons why percutaneous coronary intervention is avoided in elderly patients. This review examines past clinical trials and the existing evidence that supports performing percutaneous coronary intervention in elderly patients.Keywords
This publication has 37 references indexed in Scilit:
- Trends in the Association Between Age and In-Hospital Mortality After Percutaneous Coronary InterventionCirculation: Cardiovascular Interventions, 2009
- Enoxaparin versus Unfractionated Heparin in Elective Percutaneous Coronary InterventionNew England Journal of Medicine, 2006
- Outcome of patients aged ≥75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: Do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent revascularization?American Heart Journal, 2005
- Long-Term Outcome in Elderly Patients With Chronic Angina Managed Invasively Versus by Optimized Medical TherapyCirculation, 2004
- Primary angioplasty with routine stenting compared with thrombolytic therapy in elderly patients with acute myocardial infarctionAmerican Heart Journal, 2003
- Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: Six-month follow up and analysis of individual patient data from randomized trialsAmerican Heart Journal, 2003
- Outcomes and early revascularization for patients ≥65 years of age with cardiogenic shockThe American Journal of Cardiology, 2001
- One-year results of the thrombolysis in myocardial infarction (TIMI) IIIB clinical trialJACC, 1995
- Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesJAMA, 1995
- Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: The primary angioplasty in myocardial infarction (PAMI) trialJACC, 1995